Clinical Trials Browser

Phase 2 × Completed × ixabepilone × Clear all

NCT03093155 2024-05-14

Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab

Phase 2 Completed

78 enrolled 18 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

NCT00879086 2023-06-22

A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Participants With Advanced Breast Cancer

Phase 2 Completed

104 enrolled 16 charts

Breast Neoplasms, Neoplasms

NCT01446016 2023-01-23

CAT

Phase 2 Completed

38 enrolled 11 charts

Breast Neoplasms

NCT00828308 2022-03-08

Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer

Phase 2 Completed

16 enrolled 7 charts

Prostatic Neoplasms

NCT00741988 2021-12-15

Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer

Phase 2 Completed

82 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung

NCT00866905 2021-11-22

Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer

Phase 2 Completed

168 enrolled 7 charts

Breast Neoplasms

NCT01097642 2021-09-22

ICE

Phase 2 Completed

40 enrolled 11 charts

Breast Neoplasms

NCT00723957 2020-10-28

A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer

Phase 2 Completed

260 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung

NCT00983801 2020-10-28

Study of Ixabepilone in Asian Subjects With Unresectable or Metastatic Gastric Cancer

Phase 2 Completed

58 enrolled 13 charts

Gastrointestinal

Stomach Neoplasms

NCT01416389 2019-09-18

A Study of LY2523355 in Participants With Breast Cancer

Phase 2 Completed

39 enrolled 16 charts

Breast Neoplasms, Neoplasms, Recurrence

NCT01168232 2019-08-08

Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer

Phase 2 Completed

42 enrolled 10 charts

GynecologicSarcoma

Recurrent Uterine Corpus Sarcoma

NCT00025155 2019-07-24

Ixabepilone in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer That Has Not Responded to Previous Chemotherapy

Phase 2 Completed

51 enrolled 9 charts

Carcinoma, Ovarian Epithelial

NCT00095979 2019-07-24

Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer

Phase 2 Completed

52 enrolled 10 charts

Endometrial Neoplasms

NCT00030706 2018-09-28

Ixabepilone in Treating Patients With Relapsed and/or Refractory Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cancer

Phase 2 Completed

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT00627978 2018-06-26

Phase II Study of Ixabepilone in Metastatic Breast Cancer and Its Effects on the Ultrastructure of Neurons

Phase 2 Completed

15 enrolled 6 charts

Breast Neoplasms

NCT00923130 2018-04-17

Bevacizumab Plus Ixabepilone to Treat Patients With Advanced Kidney Cancer

Phase 2 Completed

30 enrolled 12 charts

Carcinoma, Renal Cell

NCT00058084 2017-02-23

Ixabepilone Compared With Mitoxantrone and Prednisone in Treating Patients With Refractory Metastatic Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00080262 2017-01-30

Novel Epothilone (BMS-247550) in Patients With Metastatic Breast Cancer (MBC)

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT01019577 2017-01-30

Clinical Study of Ixabepilone (BMS-247550) by Every-3-week Dosing Regimen in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and Who Are Taxane Resistant

Phase 2 Completed

Breast Neoplasms

NCT01027208 2017-01-30

A Rollover Study of Ixabepilone (BMS-247550) In Patients With Metastatic Breast Cancer Previously Treated With An Anthracycline

Phase 2 Completed

Breast Neoplasms

NCT01075100 2016-12-07

Ixabepilone + Carboplatin Metastatic Breast Cancer

Phase 2 Completed

103 enrolled 13 charts

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT00370552 2016-03-10

A Trial of 2 Schedules of Ixabepilone Plus Bevacizumab and Paclitaxel Plus Bevacizumab for Breast Cancer

Phase 2 Completed

136 enrolled 17 charts

Breast Neoplasms

NCT00383149 2016-03-10

A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer

Phase 2 Completed

58 enrolled 13 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00490646 2016-03-10

A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast Cancer

Phase 2 Completed

50 enrolled 12 charts

Breast Neoplasms

NCT00593827 2016-03-10

Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer

Phase 2 Completed

176 enrolled 16 charts

Breast Neoplasms

NCT00633464 2016-03-10

Randomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-resectable and/or Metastatic Breast Cancer

Phase 2 Completed

79 enrolled 15 charts

Breast Neoplasms

NCT00455533 2016-02-24

Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer

Phase 2 Completed

384 enrolled 26 charts

Breast Neoplasms

NCT00821886 2014-12-22

Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer

Phase 2 Completed

60 enrolled 5 charts

Breast Neoplasms

NCT00751868 2014-12-17

GIM9

Phase 2 Completed

Breast Neoplasms

NCT00331643 2014-11-14

Ixabepilone in Treating Young Patients With Refractory Solid Tumors

Phase 2 Completed

CNSGenitourinarySarcoma

Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Osteosarcoma, Sarcoma, Synovial, Neuroectodermal Tumors, Primitive, Peripheral

NCT00058019 2014-05-23

Ixabepilone in Treating Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

Phase 2 Completed

51 enrolled 14 charts

Burkitt Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell

NCT00077376 2014-05-21

Trastuzumab, Ixabepilone, and Carboplatin in Treating Patients With HER2/Neu-Positive Metastatic Breast Cancer

Phase 2 Completed

61 enrolled 12 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00087139 2014-05-09

Ixabepilone in Treating Patients With Metastatic Prostate Cancer

Phase 2 Completed

124 enrolled 10 charts

Prostatic Neoplasms

NCT00022477 2013-09-05

BMS-247550 in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00016393 2013-06-24

BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Phase 2 Completed

Prostatic Neoplasms

NCT00016965 2013-06-24

BMS-247550 in Treating Patients With Advanced Pancreatic Cancer

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT00052572 2013-06-24

Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

NCT00070096 2013-06-24

Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors

Phase 2 Completed

CNSGenitourinaryGynecologic

Testicular Germ Cell Tumor, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

NCT00045097 2013-06-20

Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT00017056 2013-06-18

BMS-247550 in Treating Patients With Recurrent Metastatic Stomach Cancer That Has Been Previously Treated With Chemotherapy

Phase 2 Completed

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT00020904 2013-06-18

BMS-247550 in Treating Women With Metastatic Breast Cancer

Phase 2 Completed

Breast Neoplasms

NCT00017043 2013-04-05

BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy

Phase 2 Completed

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

NCT00182702 2013-03-25

Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer

Phase 2 Completed

Carcinoma, Renal Cell

NCT00033618 2013-02-27

Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck

Phase 2 Completed

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

NCT00036764 2013-01-25

BMS-247550 in Treating Patients With Stage IV Melanoma

Phase 2 Completed

Melanoma

NCT00021099 2013-01-24

Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer

Phase 2 Completed

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00030992 2012-08-20

BMS 247550 to Treat Kidney Cancer

Phase 2 Completed

102 enrolled 10 charts

Carcinoma, Renal Cell, Kidney Neoplasms